Blog

27
Jun, 2017

27
Jun, 2017

JUPITER, FL May. 5, 2017 — Somahlution, a global biotechnology company developing products to reduce the burden of ischemia reperfusion injury in tissue grafting, organ transplant and other surgical indications, announces today the Medical University of Vienna has started participation to evaluate the company’s flagship product DuraGraft®, a vascular...